Detailed Information on Publication Record
2006
Proopiomelanocortin gene variability and chronic heart failure: no association so far
BIENERTOVÁ VAŠKŮ, Julie, Lenka ŠPINAROVÁ, Petr BIENERT and Anna VAŠKŮBasic information
Original name
Proopiomelanocortin gene variability and chronic heart failure: no association so far
Name in Czech
Variabilita v genu pro proopiomelanokortin u pacientů s chronickým srdečním selháním
Authors
BIENERTOVÁ VAŠKŮ, Julie (203 Czech Republic, guarantor), Lenka ŠPINAROVÁ (203 Czech Republic), Petr BIENERT (203 Czech Republic) and Anna VAŠKŮ (203 Czech Republic)
Edition
Hungary, New Frontiers in Basic Cardiovascular Research, p. 41-41, 1 pp. 2006
Publisher
INSERM, France
Other information
Language
English
Type of outcome
Stať ve sborníku
Field of Study
Genetics and molecular biology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/06:00017439
Organization unit
Faculty of Medicine
Keywords in English
genes; chronic heart failure; polymerase chain reaction; proopiomelanocortin
Změněno: 2/11/2006 14:56, prof. MUDr. Julie Dobrovolná, Ph.D.
V originále
Background: Rare mutations in the proopiomelanocortin gene (POMC) have been previously reported to cause early-onset childhood obesity and the POMC locus (2p21) has been linked to leptin levels and body mass index (BMI). Objectives: In this study, we investigated possible associations of C1032G polymorphism (dbSNP ID rs1009388) within the first intron of POMC gene with chronic heart failure. Methods: 247 patients of caucasian origin with chronic heart failure (functional classes NYHA II-IV, ejection fraction (EF) < 40%) have been investigated in comparison to 198 healthy volunteers of similar age and gender distribution. Results: No differences in genotype distributions or allelic frequencies of the examined C1032G POMC polymorphism have been observed when comparing the chronic heart failure patients and the control subjects. There was no association between any of followed patients characteristics (age, gender, diabetes I, II, hyperlipoproteinemia, NYHA class, EF, CRP plasma levels, renin plasma levels, aldosterone plasma levels, big endothelin and endothelin-1 plasma levels, fibrinogene plasma levels and glucose plasma levels) and genotypes of the polymorphism. Conclusions: Based on our results, C1032G polymorphism within the first intron of POMC gene is not associated with chronic heart failure, neither in a case-control study nor when associating specific variants of the examined polymorphism with patients characteristics.
In Czech
Neprokázali jsme statisticky signifikatní asociaci distribuce genotypů nebo alelických frekvencí polymorfismu C1032G v POMC genu s výskytech chronického srdečního selhání.
Links
MSM 141100002, plan (intention) |
|